ZME Science on MSN1h
Could CAR-T Therapy Be the End of Lifelong Lupus Medication? Early Results Say ‘Yes’
T-cells are real life saviors. If modified properly, they can save lupus patients from the trouble of taking medicines ...
News Medical15h
CAR T cell therapy breakthroughs bring new hope for treating solid tumors
Researchers advance CAR T cell therapy for solid tumors by innovating ways to overcome the unique barriers of solid tumor ...
AZoLifeSciences on MSN1d
A Closer Look at CAR T-Cell Therapy — Successes, Challenges, And Future
T-cell therapy is a revolutionary immunotherapy approach in which T cells are genetically modified to express a receptor that ...
Hosted on MSN23d
New CAR-T cells offer on-demand control for cancer treatment
Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer ...
The American Journal of Managed Care7d
KIR2DS2+ NK Cells Show Potential in HCC and Leukemia Treatment
These findings suggest that KIR2DS2-positive (KIR2DS2+) natural killer (NK) cells could be an attractive therapeutic target ...
MedPage Today on MSN6d
Overcoming the Challenges of Applying CAR T-Cell Therapy to Solid Tumors
Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ...
emjreviews.com5d
Low Prevalence of Serious Cardiovascular Events in CAR T-Cell Therapy Recipients
A recent meta-analysis investigating cardiovascular complications in adults undergoing chimeric antigen receptor (CAR) T-cell ...
Cabaletta Bio Reports Third Quarter 2024 Financial Results and Provides Business Update
Clinical data from the RESET-Myositis™ and RESET-SLE™ trials, along with initial clinical data from the RESET-SSc™ trial, to be presented this ...
Morningstar22d
Interius BioTherapeutics Doses First Patient with in vivo Chimeric Antigen Receptor (CAR) Gene Therapy for B-cell Malignancies
INT2104 is a novel in vivo chimeric antigen receptor (CAR) gene therapy designed to generate CAR-T and CAR-NK cells in the patient’s body to target CD20-expressing malignant B cells Interim ...
News Medical on MSN9d
Modulating CD39 expression to enhance CAR-T cell therapy against hepatocellular carcinoma
In the quest to enhance the efficacy of chimeric antigen receptor T (CAR-T) cell therapy against hepatocellular carcinoma (HCC), a recent study has identified a pivotal role for CD39 expression in ...